AKT1 and acute lymphoblastic leukemia: It was found that upregulated expression of SNX10 activated the PI3K-Akt signaling pathway, thereby reducing apoptosis and increasing the proportion of cells in the G2/M phase, thus promoting the proliferation of B-ALL cells and accelerating disease progression.